Cardiol Therapeutics (CRDL) Depreciation and Depletion: 2020-2024
Historic Depreciation and Depletion for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $118,877.
- Cardiol Therapeutics' Depreciation and Depletion fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $111,067, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
- Per Cardiol Therapeutics' latest filing, its Depreciation and Depletion stood at $118,877 for FY2024, which was down 2.15% from $121,485 recorded in FY2023.
- Cardiol Therapeutics' 5-year Depreciation and Depletion high stood at $121,485 for FY2023, and its period low was $104,194 during FY2022.
- In the last 3 years, Cardiol Therapeutics' Depreciation and Depletion had a median value of $118,877 in 2024 and averaged $114,852.
- As far as peak fluctuations go, Cardiol Therapeutics' Depreciation and Depletion dropped by 3.97% in 2022, and later increased by 16.59% in 2023.
- Yearly analysis of 5 years shows Cardiol Therapeutics' Depreciation and Depletion stood at $108,310 in 2020, then grew by 0.18% to $108,504 in 2021, then declined by 3.97% to $104,194 in 2022, then climbed by 16.59% to $121,485 in 2023, then decreased by 2.15% to $118,877 in 2024.